Literature DB >> 27220320

MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.

Shuai Chang1, Shicai He1, Guanglin Qiu1, Jing Lu1, Jin Wang1, Junsong Liu1, Lin Fan1, Wei Zhao1, Xiangming Che2.   

Abstract

MicroRNAs have been documented playing key roles in cancer development and progression. Here, we investigate the role of miR-125b in gastric cancer metastasis. We found that the expression of miR-125b was up-regulated in gastric cancer tissue specimens compared with their corresponding nontumorous tissues, and the up-regulated miR-125b level was significantly associated with TNM stage and lymph node-metastasis. Overexpression of miR-125b promoted gastric cancer cell migration and invasion in vitro and metastasis in vivo. STARD13 and NEU1 were identified as direct target genes of miR-125b by luciferase assays, and they were involved in the cell migration and invasion regulated by miR-125b in gastric cancer. Taken together, miR-125b functions as an oncogene in gastric cancer and represents a new potential therapeutic target for gastric cancer.

Entities:  

Keywords:  Gastric cancer; Metastasis; MicroRNA-125b; NEU1; STARD13

Mesh:

Substances:

Year:  2016        PMID: 27220320     DOI: 10.1007/s13277-016-5094-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  54 in total

1.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

Authors:  Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

2.  Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.

Authors:  Atsushi Yamada; Takahiro Horimatsu; Yoshinaga Okugawa; Naoshi Nishida; Hajime Honjo; Hiroshi Ida; Tadayuki Kou; Toshihiro Kusaka; Yu Sasaki; Makato Yagi; Takuma Higurashi; Norio Yukawa; Yusuke Amanuma; Osamu Kikuchi; Manabu Muto; Yoshiyuki Ueno; Atsushi Nakajima; Tsutomu Chiba; C Richard Boland; Ajay Goel
Journal:  Clin Cancer Res       Date:  2015-06-02       Impact factor: 12.531

3.  Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.

Authors:  Fengju Song; Da Yang; Ben Liu; Yan Guo; Hong Zheng; Lian Li; Tao Wang; Jinpu Yu; Yanrui Zhao; Ruifang Niu; Han Liang; Hans Winkler; Wei Zhang; Xishan Hao; Kexin Chen
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

4.  The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.

Authors:  Bassem D Khalil; Samer Hanna; Bechara A Saykali; Sally El-Sitt; Anita Nasrallah; Daniel Marston; Marwan El-Sabban; Klaus M Hahn; Marc Symons; Mirvat El-Sibai
Journal:  Exp Cell Res       Date:  2013-12-10       Impact factor: 3.905

5.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

6.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.

Authors:  Aki Hanyu; Kiyotsugu Kojima; Kiyohiko Hatake; Kimie Nomura; Hironori Murayama; Yuichi Ishikawa; Satoshi Miyata; Masaru Ushijima; Masaaki Matsuura; Etsuro Ogata; Keiji Miyazawa; Takeshi Imamura
Journal:  Cancer Sci       Date:  2009-08-03       Impact factor: 6.716

8.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

9.  MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.

Authors:  Ramiro Garzon; Stefano Volinia; Chang-Gong Liu; Cecilia Fernandez-Cymering; Tiziana Palumbo; Flavia Pichiorri; Muller Fabbri; Kevin Coombes; Hansjuerg Alder; Tatsuya Nakamura; Neal Flomenberg; Guido Marcucci; George A Calin; Steven M Kornblau; Hagop Kantarjian; Clara D Bloomfield; Michael Andreeff; Carlo M Croce
Journal:  Blood       Date:  2008-01-10       Impact factor: 22.113

10.  MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.

Authors:  M Kappelmann; S Kuphal; G Meister; L Vardimon; A-K Bosserhoff
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

View more
  24 in total

Review 1.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

2.  miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP.

Authors:  Tiefeng Qiu; Keping Wang; Xianwen Li; Jianhua Jin
Journal:  Exp Ther Med       Date:  2018-10-01       Impact factor: 2.447

Review 3.  Fixing the GAP: The role of RhoGAPs in cancer.

Authors:  Gabriel Kreider-Letterman; Nicole M Carr; Rafael Garcia-Mata
Journal:  Eur J Cell Biol       Date:  2022-02-10       Impact factor: 6.020

4.  MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.

Authors:  Yunping Lu; Weifen Zheng; Xiao Rao; Yinggan Du; Jianbo Xue
Journal:  Biochem Genet       Date:  2022-02-04       Impact factor: 1.890

5.  MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis.

Authors:  Philipp Lutz; Mohamed M Haimid; Alessandra Pohlmann; Jennifer Lehmann; Christian Jansen; Robert Schierwagen; Sabine Klein; Christian P Strassburg; Ulrich Spengler; Jonel Trebicka
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

6.  Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer.

Authors:  Hong Zhang; Yafei Zhang; Xixi Zhao; Xingcong Ma; Wanjun Yan; Wen Wang; Zitong Zhao; Qian Yang; Xi Sun; Hui Luan; Xiaoyan Gao; Shuqun Zhang
Journal:  Oncotarget       Date:  2017-07-18

7.  Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer.

Authors:  Qingshun Meng; Longquan Xiang; Jingwei Fu; Xianqun Chu; Chunlin Wang; Bingzheng Yan
Journal:  Oncotarget       Date:  2017-06-06

8.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

9.  Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer.

Authors:  Xiumei Jiang; Wenfei Wang; Yongmei Yang; Lutao Du; Xiaoyun Yang; Lili Wang; Guixi Zheng; Weili Duan; Rui Wang; Xin Zhang; Lishui Wang; Xiaoyang Chen; Chuanxin Wang
Journal:  Oncotarget       Date:  2017-05-10

10.  Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer.

Authors:  Birdal Bilir; Nitya V Sharma; Jeongseok Lee; Bato Hammarstrom; Aud Svindland; Omer Kucuk; Carlos S Moreno
Journal:  Int J Oncol       Date:  2017-05-24       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.